nLIGHT, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024. nLIGHT designs and manufactures high-power semiconductor and fiber lasers. It reports Laser Products and Advanced Development segments. Figures are unaudited; dollar amounts are in millions unless otherwise indicated.
Financial performance
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $44.5 | $54.1 | Down 17.7% |
| Gross profit / margin | $7.5 / 16.8% | $14.3 / 26.4% | Margin down 9.6 percentage points |
| Operating expenses | $22.2 | $22.5 | Down 1.2% |
| Operating loss | $(14.7) | $(8.2) | Loss widened |
| Net loss | $(13.8) | $(7.7) | Loss widened |
| Diluted loss per share | $(0.29) | $(0.17) | — |
| Operating cash flow | $11.4 | $0.6 | Improved |
| Capital expenditures | $1.6 | $0.7 | Increased |
Revenue mix and drivers: Laser Products revenue was $29.4 million, down 28.6%; Advanced Development revenue was $15.2 million, up 16.7%. Industrial revenue fell 39.8% and Microfabrication fell 17.3%, primarily due to lower unit sales, softer customer demand, and deteriorating market conditions. Aerospace and Defense revenue rose 2.9%, supported by new development contracts. Lower Laser Products production volumes reduced fixed-cost absorption and contributed to the decline in overall gross margin.
Cash, liquidity, and liabilities: At March 31, cash and cash equivalents were $61.3 million, marketable securities $59.8 million, and restricted cash $0.3 million. Total cash, cash equivalents, restricted cash, and marketable securities increased $8.2 million from year-end. Current assets were $219.2 million versus current liabilities of $38.3 million. The company had no borrowings under its $40 million revolving credit line; the facility expires September 24, 2024. Lease liabilities totaled $14.2 million. Management believes available liquidity is sufficient for working capital and capital expenditure needs for at least 12 months.
Material changes and other disclosures
- Operating cash flow benefited from working-capital movements, notably an $11.9 million reduction in accounts receivable and higher accounts payable and deferred revenue; it was positive despite the net loss.
- Revenue from Rest of World declined 41.9%, while North America was down 1.3% and China down 6.4%.
- Two customers accounted for a combined 30% of net receivables at quarter-end, compared with 24% at December 31, 2023. The U.S. Government represented 19% of quarterly revenue; Raytheon Technologies and KORD Technologies represented 11% and 10%, respectively.
- Firm fixed-price contract performance obligations not subject to disclosure exemptions totaled $25 million; the company expects to recognize 75% by year-end 2024 and the balance by year-end 2025.
Outlook, risks, and contingencies
- The filing provides no specific financial guidance. Management says it anticipates increased product volumes and continued introductions of new, higher-value products, while noting that lower demand, pricing pressure, and market conditions may constrain revenue and margins.
- Performance depends on customer capital spending, design wins, product mix, manufacturing utilization and yields, and continued U.S. government and allied investment in aerospace and defense laser technology. Seasonality and supply-chain, trade, tariff, and competitive dynamics may also affect results.
- A $40 million revolving credit facility is available but expires in September 2024; the company reported covenant compliance and no amounts drawn. Management may explore additional financing in the future.
- In pending litigation, Lumentum alleges ownership of certain nLIGHT patents and seeks related relief. nLIGHT is defending the case; management states a loss is not probable or reasonably estimable and has recorded no contingency.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting during the quarter. It reported no material changes to the risk factors in its 2023 Form 10-K.
Investor verification priorities
- Track whether industrial and microfabrication demand, product volumes, and manufacturing utilization recover, and whether Laser Products margins stabilize.
- Assess whether Advanced Development contract growth and the expected recognition of the $25 million performance-obligation balance translate into revenue and cash collection as planned.
- Monitor operating cash flow quality and working-capital trends, especially receivables, deferred revenue, and inventory.
- Verify renewal or replacement of the revolving credit facility before its September 2024 expiration and review future liquidity needs.
- Follow developments in the Lumentum patent litigation and customer concentration in receivables and revenue.